Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8294-8303
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8294
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8294
Figure 1 Proposed mechanisms of nonalcoholic fatty liver disease-hepatocellular carcinoma.
1Mechanism has been identified in nonalcoholic fatty liver disease in the absence of cirrhosis. IGF-1: Insulin-like growth factor-1; IRS-1: Insulin receptor substrate-1; M6P/IGF2R: Mannose 6-phosphate/insulin-like growth factor-2 receptor; FFA: Free fatty acids; ROS: Reactive oxidative species; TNF-α: Tumor necrosis factor-alpha; IL-6: Interleukin-6; STAT3: Signal transducer and activator of transcription; JNK1: c-Jun amino-terminal kinase 1; PNPLA3: Patatin-like phospholipase domain-containing protein 3.
- Citation: Wong CR, Nguyen MH, Lim JK. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(37): 8294-8303
- URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i37.8294